Drug intelligence / Profile preview

Coraz

Development stage: Unknown
Modality: Small Molecules

Overview

**Coraz** is a non-specific marketed brand name that refers to at least two distinct pharmaceutical products. In India, Coraz 250 mg and Coraz 500 mg tablets contain **azithromycin**, an oral macrolide antibiotic used for susceptible bacterial infections. Separately, Coraz has also been used for a topical dermatology kit containing **hydrocortisone, salicylic acid, and sulfur**. These products have different active ingredients, routes of administration, mechanisms, and therapeutic uses; therefore, the name alone cannot be resolved to one drug entity.

Brand names: Coraz

Beyond the preview

Go deeper on Coraz.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Coraz.

Explore the full profile